Kuva Merger Collapse Forces Lisata Therapeutics Retrenchment
Lisata Therapeutics terminated its planned merger with Kuva Labs, filed suit alleging breach of the agreement, and implemented a reduction in force affecting approximately 72% of full-time employees. The company is seeking damages and…
